Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes
Reps will raise questions about whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes.
They're sharing new data that suggest insulin degludec U-100 has a lower risk of symptomatic hypoglycemia than insulin glargine U-100.
But help put this in perspective.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote